Clinical experience with fluphenazine decanoate in psychoses
Náhunek, K.; Rodová, A.; Svestka, J.
Activitas Nervosa Superior 12(1): 47-49
1970
ISSN/ISBN: 0001-7604 PMID: 5460564 Document Number: 30783
Document emailed within 1 workday
Related Documents
Small, J.G.; Kellams, J. 1974: Early hospital experience with fluphenazine decanoate Diseases of the Nervous System 35(10): 453-456Grosser, H.H. 1970: Experience of psychiatric management of schizophrenia with fluphenazine decanoate Diseases of the Nervous System 31(Suppl): 32-36
Chandra, O.; Bernard, J.; Matussek, N. 1974: Long-term trial of fluphenazine decanoate and flupenthixol decanoate for cataleptic activity and effect on motor activity in rats Arzneimittel-Forschung 24(11): 1821-1824
Stevens, B. 1976: The social value of fluphenazine decanoate Acta Psychiatrica Belgica 76(5): 792-804
Timm, U.; Pfeifer, S. 1973: Assay and determination of fluphenazine decanoate in oily solution Die Pharmazie 28(11): 793
Drtil, J. 1989: Treatment of patients dependent on tobacco with fluphenazine decanoate Activitas Nervosa Superior 31(2): 116-117
Adamson, L.; Curry, S.H.; Bridges, P.K.; Firestone, A.F.; Lavin, N.I.; Lewis, D.M.; Watson, R.D.; Xavier, C.M.; Anderson, J.A. 1973: Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine Diseases of the Nervous System 34(4): 181-191
Cesková, E.; Svestka, J.; Rysánek, R. 1993: Intraindividual comparison of haloperidol decanoate and oxyprothepine in maintenance therapy in schizophrenic psychoses Ceskoslovenska Psychiatrie 89(1): 11-14
Baldini, J.T.; Neary, E.R. 1970: Controlled trials of an amitriptyline-fluphenazine combination in depressive neuroses and psychoses: a collaborative study Current Therapeutic Research 12(2): 84-93
Zapletálek, M.; Hubsch, T.; Kindernayová, H. 1975: Clinical experience with sydnocarb in neuroses and psychoses Activitas Nervosa Superior 17(4): 235-236
Król, K.; Krystof, J. 1974: Personal experience with prolonged-action fluphenazine Psychiatria Polska 8(2): 149-155
Ereshefsky, L.; Saklad, S.R.; Tran-Johnson, T.; Toney, G.; Lyman, R.C.; Davis, C.M. 1990: Kinetics and clinical evaluation of haloperidol decanoate loading dose regimen Psychopharmacology Bulletin 26(1): 108-114
Ellerman, L.A. 1987: Open clinical trial with haloperidol decanoate in patients with psychotic disorders Acta Psiquiatrica y Psicologica de America Latina 33(2): 157-162
Taussigová, D.; Prokopová, Z.; Bastecký, J.; Vinar, O. 1973: Experience with long-acting depot--neuroleptics in schizophrenic psychoses Activitas Nervosa Superior 15(2): 83-84
Vaindrukh, F.A.; Nazarov, K.N. 1973: Constitution and psychoses (body build and psychoses) (review of the literature) Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 73(1): 140-148
Dencker, S.J.; Elgen, K. 1980: Aspects of clinical psychiatric research on depot neuroleptics. The presentation of two double-blind trials with cis(z)-clopenthixol decanoate and a withdrawal study in schizophrenics Acta Psychiatrica Scandinavica. Supplementum 279: 5-9
Huhn, A.; Drenk, K. 1973: Clinical classification and prognosis of postpartum-psychoses Fortschritte der Neurologie Psychiatrie und Ihrer Grenzgebiete 41(7): 363-377
Goudemand, M.; Goudemand, J.; Goudemand-Joubert, C.; Parquet, P.J. 1981: Heredity and childhood psychoses : histocompatibility antigens (HLA a and B) and early onset childhood psychoses Acta Psychiatrica Belgica 81(1): 57-71
Torre, E.; Ancona, M. 1984: Alternating epileptic psychoses. Review of the literature and clinical cases Minerva Psichiatrica 25(4): 245-251
Ficker, F. 1977: Ambulatory and daily clinical drug therapy of depressive psychoses Zeitschrift für Arztliche Fortbildung 71(8): 403-407